Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,421 public trials 1,317 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)

NCT01540461

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Local Institution Beijing, Beijing Municipality, China

Local Institution Harbin, Heilongjiang, China

Local Institution Nanjing, Jiangsu, China

View Trial Details

Completed

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

NCT01581138

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +15 more
Locations: Birmingham, Alabama, United States

Anaheim, California, United States

Riverside, California, United States

San Diego, California, United States

View all 18 locations

View Trial Details

Completed

Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease

NCT02176811

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Gulhane School of Medicine Department of Endocrinology and Metabolism Ankara, Turkey (Türkiye)

View Trial Details

Completed

Absolute Bioavailability of BMS-791325

NCT02112110

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Local Institution Nottingham, Nottinghamshire, United Kingdom

View Trial Details

Completed

An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants

NCT00528528

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Vienna, Austria

Brussels, Belgium

Ghent, Belgium

Leuven, Belgium

View all 24 locations

View Trial Details

Completed

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function

NCT02170571

Conditions: Digestive System Diseases, Hepatic Insufficiency, Liver Diseases
Locations: Not specified

View Trial Details

Completed

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV

NCT00725803

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations: Anaheim, California, United States

Washington D.C., District of Columbia, United States

Orlando, Florida, United States

Dallas, Texas, United States

View Trial Details

Completed

Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects

NCT02045966

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

Drug Interaction & Methadone & Buprenorphine

NCT02045693

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Anaheim Clinical Trials Llc Anaheim, California, United States

Cri Lifetree Philadelphia, Pennsylvania, United States

Lifetree Clinical Research Salt Lake City, Utah, United States

View Trial Details

Completed

Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD

NCT00585299

Conditions: Digestive System Diseases, Fatty Liver, Glucose Metabolism Disorders, +5 more
Locations: Yale University School of Medicine New Haven, Connecticut, United States

View Trial Details

Liver Diseases

Liver Diseases trial results

Related conditions